Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Tert-Butyl Hypochlorite, also known as Hypochlorous Acid tert-Butyl Ester, is a slightly yellowish liquid with a pungent odor. It is water-insoluble and has a flash point near 0°F. Tert-Butyl Hypochlorite is corrosive to the skin, eyes, and mucous membranes. It is a compound useful in organic synthesis.

507-40-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 507-40-4 Structure
  • Basic information

    1. Product Name: tert-Butyl Hypochlorite
    2. Synonyms: HYPOCHLOROUS ACID TERT-BUTYL ESTER;Hypochlorous acid, 1,1-dimethylethyl ester;Hypochlorousacid,1,1-dimethylethylester;t-Butyl hypochlorite;tert-C4H9OCl;TERT-BUTYL HYPOCHLORITE;Hypochlorousaciddibutylester;HYPOCHLOROUS ACID TERT-BUTYL ESTER 98+%
    3. CAS NO:507-40-4
    4. Molecular Formula: C4H9ClO
    5. Molecular Weight: 108.57
    6. EINECS: 208-072-7
    7. Product Categories: Chlorination;Halogenation;Oxidation;Synthetic Organic Chemistry;Miscellaneous Reagents
    8. Mol File: 507-40-4.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 79.6℃ (750 Torr)
    3. Flash Point: °C
    4. Appearance: yellowish liquid with an irritating odour
    5. Density: 0.96
    6. Vapor Pressure: 106mmHg at 25°C
    7. Refractive Index: 1.4010-1.4050
    8. Storage Temp.: Refrigerator
    9. Solubility: Chloroform (Sparingly), Ethyl Acetate (Slightly)
    10. Stability: Unstable. Light-sensitive. Highly flammable. Incompatible with strong oxidizing agents. Keep refrigerated below 10 C.
    11. Merck: 14,1571
    12. CAS DataBase Reference: tert-Butyl Hypochlorite(CAS DataBase Reference)
    13. NIST Chemistry Reference: tert-Butyl Hypochlorite(507-40-4)
    14. EPA Substance Registry System: tert-Butyl Hypochlorite(507-40-4)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: 36/37/38
    3. Safety Statements: 26-36/37/39
    4. RIDADR: 3255
    5. WGK Germany:
    6. RTECS:
    7. HazardClass: 4.2/8
    8. PackingGroup: N/A
    9. Hazardous Substances Data: 507-40-4(Hazardous Substances Data)

507-40-4 Usage

Uses

1. Used in Organic Synthesis:
Tert-Butyl Hypochlorite is used as a reagent for organic synthesis due to its ability to facilitate various chemical reactions.
2. Used in Dehydration of Alcohols:
Tert-Butyl Hypochlorite is used as a dehydrating agent for alcohols, enabling the conversion of alcohols into alkenes or alkynes.
3. Used in Nand C-chlorinations:
Tert-Butyl Hypochlorite is utilized as a chlorinating agent for nitrogen and carbon atoms in organic compounds, leading to the formation of N-chlorinated and C-chlorinated products.
4. Used in Chemical Research:
Tert-Butyl Hypochlorite is employed in chemical research for studying its properties and potential applications in various chemical processes.

Air & Water Reactions

May ignite on contact with air or moist air. May burn rapidly with flare-burning effect. Water insoluble. Decomposed exothermically by water with the evolution of toxic chlorine gas.

Reactivity Profile

HYPOCHLOROUS ACID TERT-BUTYL ESTER decomposes exothermically when exposed to UV light to give acetone and chloromethane. Glass containers have burst because of pressure buildup after exposure to fluorescent lighting or daylight. Reacts violently with rubber. Should not be heated to its boiling point.

Health Hazard

Fire will produce irritating, corrosive and/or toxic gases. Inhalation of decomposition products may cause severe injury or death. Contact with substance may cause severe burns to skin and eyes. Runoff from fire control may cause pollution.

Fire Hazard

Flammable/combustible material. May ignite on contact with moist air or moisture. May burn rapidly with flare-burning effect. Some react vigorously or explosively on contact with water. Some may decompose explosively when heated or involved in a fire. May re-ignite after fire is extinguished. Runoff may create fire or explosion hazard. Containers may explode when heated.

Check Digit Verification of cas no

The CAS Registry Mumber 507-40-4 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,0 and 7 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 507-40:
(5*5)+(4*0)+(3*7)+(2*4)+(1*0)=54
54 % 10 = 4
So 507-40-4 is a valid CAS Registry Number.
InChI:InChI=1/C4H9ClO/c1-4(2,3)6-5/h1-3H3

507-40-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (H0362)  tert-Butyl Hypochlorite  >98.0%(T)

  • 507-40-4

  • 25g

  • 350.00CNY

  • Detail
  • TCI America

  • (H0362)  tert-Butyl Hypochlorite  >98.0%(T)

  • 507-40-4

  • 500g

  • 3,080.00CNY

  • Detail

507-40-4Synthetic route

tert-butyl alcohol
75-65-0

tert-butyl alcohol

tert-butylhypochlorite
507-40-4

tert-butylhypochlorite

Conditions
ConditionsYield
With sodium hypochlorite; acetic acid In water at 0℃; for 0.166667h; Darkness;75%
With sodium hypochlorite; acetic acid at 20 - 25℃;72.2%
With acetic acid for 0.05h;66%
hypochloric acid
14989-30-1

hypochloric acid

tert-butyl alcohol
75-65-0

tert-butyl alcohol

tert-butylhypochlorite
507-40-4

tert-butylhypochlorite

Conditions
ConditionsYield
In tetrachloromethane; water shaking a soln. of alcohol in CCl4 with an aq. soln. of HClO;; soln. of ester in CCl4 obtained;;
In tetrachloromethane; water shaking a soln. of alcohol in CCl4 with an aq. soln. of HClO;; soln. of ester in CCl4 obtained;;
sodium hypochlorite
7681-52-9

sodium hypochlorite

tert-butyl alcohol
75-65-0

tert-butyl alcohol

tert-butylhypochlorite
507-40-4

tert-butylhypochlorite

Conditions
ConditionsYield
With acetic acid at 0℃; Darkness;
{bis(trimethylsilyl)amino}-(t-butylimino)phosphane
54760-90-6, 95792-83-9

{bis(trimethylsilyl)amino}-(t-butylimino)phosphane

tert-butylhypochlorite
507-40-4

tert-butylhypochlorite

tert-butyl N-tert-butyl-N,N'-bis(trimethylsilyl)phosphoramidochloridimidate
79202-19-0

tert-butyl N-tert-butyl-N,N'-bis(trimethylsilyl)phosphoramidochloridimidate

Conditions
ConditionsYield
In benzene for 2h; Ambient temperature;100%
N-trimethylsilylimidophosphenous acid 2,2,6,6-tetramethylpiperidine
72821-01-3

N-trimethylsilylimidophosphenous acid 2,2,6,6-tetramethylpiperidine

tert-butylhypochlorite
507-40-4

tert-butylhypochlorite

P-chloro-O-tert-butyl-2,2,6,6-tetramethylpiperidido-N-trimethylsilylimidophosphate

P-chloro-O-tert-butyl-2,2,6,6-tetramethylpiperidido-N-trimethylsilylimidophosphate

Conditions
ConditionsYield
In benzene at 0℃; for 1h; argon atmosphere;100%
tert-butylhypochlorite
507-40-4

tert-butylhypochlorite

N-propylbenzohydroxamic acid
72805-06-2

N-propylbenzohydroxamic acid

N-chloro-N-propoxybenzamide

N-chloro-N-propoxybenzamide

Conditions
ConditionsYield
In dichloromethane for 3h; anhydrous;100%
tert-butylhypochlorite
507-40-4

tert-butylhypochlorite

2-chloro-1-(4-isopropylphenyl)-2-methylpropan-1-one

2-chloro-1-(4-isopropylphenyl)-2-methylpropan-1-one

2-chloro-1-(4-(2-chloropropan-2-yl)phenyl)-2-methylpropan-1-one

2-chloro-1-(4-(2-chloropropan-2-yl)phenyl)-2-methylpropan-1-one

Conditions
ConditionsYield
In chlorobenzene at -10 - 20℃; Inert atmosphere;100%
tert-butylhypochlorite
507-40-4

tert-butylhypochlorite

N,N,N'-tris(trimethylsilyl)phosphenimidous amide
50732-21-3, 65428-75-3

N,N,N'-tris(trimethylsilyl)phosphenimidous amide

tert-butyl tris(trimethylsilyl)phosphoramidochlorimidate
79202-16-7

tert-butyl tris(trimethylsilyl)phosphoramidochlorimidate

Conditions
ConditionsYield
In benzene for 2h; Ambient temperature;98%
tert-butylhypochlorite
507-40-4

tert-butylhypochlorite

N'-(1-adamantyl)-N,N-bis(trimethylsilyl)phosphorimidous amide
76889-11-7

N'-(1-adamantyl)-N,N-bis(trimethylsilyl)phosphorimidous amide

C20H42ClN2OPSi2
79202-21-4

C20H42ClN2OPSi2

Conditions
ConditionsYield
In benzene for 2h; Ambient temperature;95%
tert-butylhypochlorite
507-40-4

tert-butylhypochlorite

(1,3-dimethylimidazol-2-ylidene)borane
1211417-77-4

(1,3-dimethylimidazol-2-ylidene)borane

(1,3-dimethyl-1H-imidazolium-2-yl)trichloroborate
1352941-55-9

(1,3-dimethyl-1H-imidazolium-2-yl)trichloroborate

Conditions
ConditionsYield
In dichloromethane at -78 - 20℃; for 1.05h; Schlenk technique; Inert atmosphere;94%
tert-butylhypochlorite
507-40-4

tert-butylhypochlorite

N,N'-bis(t-butyl)-N-(trimethylsilyl)-phosphenimidous amide
53787-01-2, 87938-40-7

N,N'-bis(t-butyl)-N-(trimethylsilyl)-phosphenimidous amide

tert-butyl N,N'-di-tert-butyl-N-(trimethylsilyl)phosphoramidochloridimidate
79202-23-6

tert-butyl N,N'-di-tert-butyl-N-(trimethylsilyl)phosphoramidochloridimidate

Conditions
ConditionsYield
In benzene for 2h; Ambient temperature;93%
tert-butylhypochlorite
507-40-4

tert-butylhypochlorite

LY 292223
130735-56-7

LY 292223

3-Chloro-2-(4-morpholinyl)-4H-1-benzopyran-4-one
130735-75-0

3-Chloro-2-(4-morpholinyl)-4H-1-benzopyran-4-one

Conditions
ConditionsYield
In dichloromethane; ethyl acetate91%
tert-butylhypochlorite
507-40-4

tert-butylhypochlorite

2,4-dihydroxy-trifluoroacetophenone
182951-75-3

2,4-dihydroxy-trifluoroacetophenone

2,4-Dihydroxy-3-chloro-trifluoroacetophenone

2,4-Dihydroxy-3-chloro-trifluoroacetophenone

Conditions
ConditionsYield
In tetrachloromethane90%
tetrachloromethane
56-23-5

tetrachloromethane

(H3)triosmiumnonacarbonyl(μ3-CH)

(H3)triosmiumnonacarbonyl(μ3-CH)

tert-butylhypochlorite
507-40-4

tert-butylhypochlorite

(H3)triosmiumnonacarbonyl(μ3-CCl)

(H3)triosmiumnonacarbonyl(μ3-CCl)

Conditions
ConditionsYield
Heating H3Os3(CO)9(μ3-CH) at 45°C in CO-saturated CCl4 with excess t-BuOCl.; TLC on fluorescent silica (pentane);90%
(H3)triosmiumnonacarbonyl(μ3-CH)

(H3)triosmiumnonacarbonyl(μ3-CH)

tert-butylhypochlorite
507-40-4

tert-butylhypochlorite

Bromotrichloromethane
75-62-7

Bromotrichloromethane

(H3)triosmiumnonacarbonyl(μ3-CBr)

(H3)triosmiumnonacarbonyl(μ3-CBr)

Conditions
ConditionsYield
Heating H3Os3(CO)9(μ3-CH) at 45°C in CO-saturated BrCCl3 with excess t-BuOCl.; TLC on fluorescent silica (pentane);90%
tert-butylhypochlorite
507-40-4

tert-butylhypochlorite

phenylacetylene
536-74-3

phenylacetylene

benzoic acid
65-85-0

benzoic acid

1-(tert-butoxy)-2,2-dichloro-2-phenylethyl benzoate

1-(tert-butoxy)-2,2-dichloro-2-phenylethyl benzoate

Conditions
ConditionsYield
With tetrachloromethane at 30℃; for 2h; Schlenk technique;90%
tert-butylhypochlorite
507-40-4

tert-butylhypochlorite

(C4H9)2(C6H5)SnCH(CH3)CH(CH3)OH

(C4H9)2(C6H5)SnCH(CH3)CH(CH3)OH

threo-iodo{3-(pivaloyloxy)but-2-yl}dibutylstannane

threo-iodo{3-(pivaloyloxy)but-2-yl}dibutylstannane

Conditions
ConditionsYield
With pyridine In diethyl ether byproducts: HCl; for 1 h at 0°C;; filtn.; washing with satd. CuSO4 soln. and NaHCO3 soln.; drying;;89%
3-(3-Acetaminophenyl)methyl-2,3,3a4,5,9b-hexahydro-1H-oxo-benz[e]isoindole

3-(3-Acetaminophenyl)methyl-2,3,3a4,5,9b-hexahydro-1H-oxo-benz[e]isoindole

3-(3-acetaminophenyl)methyl-2,3,3a,4,5,9b-hexahydro-1H-oxo-benz[e]isoindole
140378-02-5

3-(3-acetaminophenyl)methyl-2,3,3a,4,5,9b-hexahydro-1H-oxo-benz[e]isoindole

tert-butylhypochlorite
507-40-4

tert-butylhypochlorite

3-(5-Acetamino-2-chlorophenyl)methyl-2,3,3a,4,5,9b-hexahydro-1H-oxo-benz[e]isoindole
140378-03-6

3-(5-Acetamino-2-chlorophenyl)methyl-2,3,3a,4,5,9b-hexahydro-1H-oxo-benz[e]isoindole

Conditions
ConditionsYield
In chloroform86%
3-(3-acetaminophenyl)methyl-2,3,3a,4,5,9b-hexahydro-1H-oxo-benz[e]isoindole
140378-02-5

3-(3-acetaminophenyl)methyl-2,3,3a,4,5,9b-hexahydro-1H-oxo-benz[e]isoindole

tert-butylhypochlorite
507-40-4

tert-butylhypochlorite

3-(5-Acetamino-2-chlorophenyl)methyl-2,3,3a,4,5,9b-hexahydro-1H-oxo-benz[e]isoindole
140378-03-6

3-(5-Acetamino-2-chlorophenyl)methyl-2,3,3a,4,5,9b-hexahydro-1H-oxo-benz[e]isoindole

Conditions
ConditionsYield
In chloroform86%
tert-butylhypochlorite
507-40-4

tert-butylhypochlorite

6α-bromopenicillanic acid pivalolyloxymethyl ester
76468-87-6

6α-bromopenicillanic acid pivalolyloxymethyl ester

(pivaloyloxy)methyl 2-<(2'S,3'R)-2'-tert-butoxy-3'-bromo-4'-oxoazetidin-1'-yl>-3-methylbut-2-enoate
122348-01-0

(pivaloyloxy)methyl 2-<(2'S,3'R)-2'-tert-butoxy-3'-bromo-4'-oxoazetidin-1'-yl>-3-methylbut-2-enoate

Conditions
ConditionsYield
With 1-methyl-piperazine In chloroform for 0.166667h; Ambient temperature;85%
tert-butylhypochlorite
507-40-4

tert-butylhypochlorite

methoxy-1 trimethylsiloxy-2 styrene
81699-72-1

methoxy-1 trimethylsiloxy-2 styrene

2-tert-Butoxy-2-methoxy-1-phenyl-ethanone
81699-78-7

2-tert-Butoxy-2-methoxy-1-phenyl-ethanone

Conditions
ConditionsYield
With mercury(II) oxide; tetrakis(triphenylphosphine) palladium(0) In toluene at -78℃; for 1h;85%
tert-butylhypochlorite
507-40-4

tert-butylhypochlorite

(C4H9)2(C6H5)SnCH(CH3)CH(CH3)OH

(C4H9)2(C6H5)SnCH(CH3)CH(CH3)OH

erythro-iodo-{3-(pivaloyloxy)but-2-yl}dibutylstannane

erythro-iodo-{3-(pivaloyloxy)but-2-yl}dibutylstannane

Conditions
ConditionsYield
With pyridine In diethyl ether byproducts: HCl; for 1 h at 0°C;; filtn.; washing with satd. CuSO4 soln. and NaHCO3 soln.; drying;;85%
tert-butylhypochlorite
507-40-4

tert-butylhypochlorite

water
7732-18-5

water

2-(1-chloro-2-hydroxy-2-phenylethyl)-6-methyl-1,3,6,2-dioxazaborocane-4,8-dione

2-(1-chloro-2-hydroxy-2-phenylethyl)-6-methyl-1,3,6,2-dioxazaborocane-4,8-dione

C13H15BClNO5

C13H15BClNO5

Conditions
ConditionsYield
With pyridine-4-carboxylic acid In acetone at -15℃;A 85%
B 6%
tert-butylhypochlorite
507-40-4

tert-butylhypochlorite

ammonia
7664-41-7

ammonia

chloroamine
12190-75-9

chloroamine

Conditions
ConditionsYield
In methanol; tert-butyl alcohol at -40℃;80%
In neat (no solvent) equimolar amounts;; detection by spectroscopy;;
tert-butylhypochlorite
507-40-4

tert-butylhypochlorite

2-amino-5-bromo-3-methylbenzonitrile
1093966-37-0

2-amino-5-bromo-3-methylbenzonitrile

2,2'-(diazene-1,2-diyl)bis(5-bromo-3-methylbenzonitrile)

2,2'-(diazene-1,2-diyl)bis(5-bromo-3-methylbenzonitrile)

Conditions
ConditionsYield
With potassium iodide In acetonitrile at -10℃; Temperature; Inert atmosphere;80%
tert-butylhypochlorite
507-40-4

tert-butylhypochlorite

1-ethyl-3-methylimidazolium dicyanodihydridoborate

1-ethyl-3-methylimidazolium dicyanodihydridoborate

C2BCl2N2(1-)*C6H11N2(1+)

C2BCl2N2(1-)*C6H11N2(1+)

Conditions
ConditionsYield
In dichloromethane at 0 - 20℃; for 12h; Darkness;79%
tert-butylhypochlorite
507-40-4

tert-butylhypochlorite

C14H15BFNO4

C14H15BFNO4

water
7732-18-5

water

C14H16BClFNO5

C14H16BClFNO5

Conditions
ConditionsYield
With pyridine-4-carboxylic acid In acetone at -15℃; Reagent/catalyst; Solvent; Temperature;78%
tert-butylhypochlorite
507-40-4

tert-butylhypochlorite

(2S,3S)-3-(tert-butyldiphenylsilyloxy)-2-methylbutanal oxime
1132969-93-7

(2S,3S)-3-(tert-butyldiphenylsilyloxy)-2-methylbutanal oxime

(S,Z)-1-(trityloxy)pent-3-en-2-ol
1132969-94-8

(S,Z)-1-(trityloxy)pent-3-en-2-ol

(R)-1-((4S,5R)-3-((2S,3S)-3-(tert-butyldiphenylsilyloxy)butan-2-yl)-4-methyl-4,5-dihydroisoxazol-5-yl)-2-(trityloxy)ethanol
1132969-95-9

(R)-1-((4S,5R)-3-((2S,3S)-3-(tert-butyldiphenylsilyloxy)butan-2-yl)-4-methyl-4,5-dihydroisoxazol-5-yl)-2-(trityloxy)ethanol

Conditions
ConditionsYield
Stage #1: tert-butylhypochlorite; (2S,3S)-3-(tert-butyldiphenylsilyloxy)-2-methylbutanal oxime In dichloromethane at -78℃; Inert atmosphere;
Stage #2: (S,Z)-1-(trityloxy)pent-3-en-2-ol With ethylmagnesium bromide In diethyl ether; dichloromethane; isopropyl alcohol at 0 - 20℃; Inert atmosphere;
76%
tert-butylhypochlorite
507-40-4

tert-butylhypochlorite

phenylacetylene
536-74-3

phenylacetylene

Trimethylacetic acid
75-98-9

Trimethylacetic acid

1-(tert-butoxy)-2,2-dichloro-2-phenylethyl pivalate

1-(tert-butoxy)-2,2-dichloro-2-phenylethyl pivalate

Conditions
ConditionsYield
With tetrachloromethane at 60℃; for 1h; Schlenk technique;76%
2-Picolinic acid
98-98-6

2-Picolinic acid

tert-butylhypochlorite
507-40-4

tert-butylhypochlorite

phenylacetylene
536-74-3

phenylacetylene

1-(tert-butoxy)-2,2-dichloro-2-phenylethyl picolinate

1-(tert-butoxy)-2,2-dichloro-2-phenylethyl picolinate

Conditions
ConditionsYield
With tetrachloromethane at 30℃; for 1h; Schlenk technique;76%
tert-butylhypochlorite
507-40-4

tert-butylhypochlorite

o-toluidine
95-53-4

o-toluidine

2-methyl-6-(thiomethoxymethyl)-aniline

2-methyl-6-(thiomethoxymethyl)-aniline

Conditions
ConditionsYield
With sodium methylate In methanol; dichloromethane; water75%
With sodium methylate In methanol; dichloromethane; water75%

507-40-4Relevant articles and documents

A modular, low footprint and scalable flow platform for the expedient α-aminohydroxylation of enolizable ketones

Kassin, Victor-Emmanuel H.,Morodo, Romain,Toupy, Thomas,Jacquemin, Isaline,Van Hecke, Kristof,Robiette, Rapha?l,Monbaliu, Jean-Christophe M.

supporting information, p. 2336 - 2351 (2021/04/07)

The unique reactivity profile of α-chloronitroso derivatives is expressed to its fullest potential through the development of an integrated, modular and scalable continuous flow process for the electrophilic α-aminohydroxylation of various enolizable ketones. Flow conditions contribute to mitigating the high reactivity and toxicity of α-chloronitroso derivatives and provide an efficient, versatile and safe protocol for the α-aminohydroxylation of ketones with a minimal footprint. Fundamental aspects of the α-aminohydroxylation process were computed by DFT and further supported the experimental observations, hence leading to the unprecedented α-chloronitroso-based α-aminohydroxylation of primary, secondary and tertiary substrates. Recycling of the carbon backbone of the α-chloronitroso derivatives provides a high atom economy for the preparation of value-added molecules. This work showcases α-chloronitroso derivatives as economic and efficient vehicles for transferring electrophilic synthons of hydroxylamine toward nucleophilic enolates. A representative range of precursors and analogs of pharmaceutical active ingredients, including WHO essentials and drugs in shortage (such as epinephrine and ketamine), are prepared within minutes according to a fully concatenated process. The process features sequential modules with distinct unit operations including chemical transformations and multiple in-line extractions. The process relies on an upstream chemical Generator that manages the preparation of α-chloronitroso derivatives and that feeds downstream a series of α-aminohydroxylation modules. The setup is amenable to the addition of libraries of compounds for feeding upstream the process of discovery in medicinal chemistry and is transposable to pilot scale. Several layers of in-line analytical procedures are featured to improve process control and safety.

Tetrasubstituted 1,3-Enynes by Gold-Catalyzed Direct C(sp2)-H Alkynylation of Acceptor-Substituted Enamines

Han, Chunyu,Tian, Xianhai,Zhang, Huili,Rominger, Frank,Hashmi, A. Stephen K.

supporting information, p. 4764 - 4768 (2021/06/30)

A gold-catalyzed synthesis of tetrasubstituted 1,3-enynes from hypervalent iodine(III) reagents and activated alkenes is reported. This reaction involves an in situ formed alkynyl Au(III) species and a subsequent direct C(sp2)-H functionalization of alkenes, offering 26 enynes in 62-92% yield with excellent functional group tolerance.

Dual Gold/Silver Catalysis: Indolizines from 2-Substituted Pyridine Derivatives via a Tandem C(sp3)–H Alkynylation/Iminoauration

Han, Chunyu,Liu, Yaowen,Tian, Xianhai,Rominger, Frank,Hashmi, A. Stephen K.

supporting information, p. 9480 - 9484 (2021/12/17)

A dual gold/silver-catalyzed cascade C(sp3)–H alkynylation/iminoauration of 2-substituted pyridines with hypervalent iodine(III) reagents for the synthesis of indolizines is described. This novel reaction involves the formation of an alkynyl Au(III) species, a dual gold/silver-catalyzed C(sp3)–H functionalization, and a subsequent iminoauration process. A number of indolizines bearing diverse functionalities were prepared in good to excellent yield. Furthermore, a gram-scale reaction was efficiently conducted.

Twofold Radical-Based Synthesis of N, C-Difunctionalized Bicyclo[1.1.1]pentanes

Anderson, Edward A.,Mousseau, James. J.,Nugent, Jeremy,Owen, Benjamin,Pickford, Helena D.,Smith, Russell C.

supporting information, p. 9729 - 9736 (2021/07/19)

Bicyclo[1.1.1]pentylamines (BCPAs) are of growing importance to the pharmaceutical industry as sp3-rich bioisosteres of anilines and N-tert-butyl groups. Here we report a facile synthesis of 1,3-disubstituted BCPAs using a twofold radical functionalization strategy. Sulfonamidyl radicals, generated through fragmentation of α-iodoaziridines, undergo initial addition to [1.1.1]propellane to afford iodo-BCPAs; the newly formed C-I bond in these products is then functionalized via a silyl-mediated Giese reaction. This chemistry also translates smoothly to 1,3-disubstituted iodo-BCPs. A wide variety of radical acceptors and iodo-BCPAs are accommodated, providing straightforward access to an array of valuable aniline-like isosteres.

Silicon-Free SuFEx Reactions of Sulfonimidoyl Fluorides: Scope, Enantioselectivity, and Mechanism

Baggerman, Jacob,Jordaan, Daan,Liang, Dong-Dong,Streefkerk, Dieuwertje E.,Wagemakers, Jorden,Zuilhof, Han

supporting information, p. 7494 - 7500 (2020/03/23)

SuFEx reactions, in which an S?F moiety reacts with a silyl-protected phenol, have been developed as powerful click reactions. In the current paper we open up the potential of SuFEx reactions as enantioselective reactions, analyze the role of Si and outline the mechanism of this reaction. As a result, fast, high-yielding, “Si-free” and enantiospecific SuFEx reactions of sulfonimidoyl fluorides have been developed, and their mechanism shown, by both experimental and theoretical methods, to yield chiral products.

Merging Natural Products: Muraymycin–Sansanmycin Hybrid Structures as Novel Scaffolds for Potential Antibacterial Agents

Niro, Giuliana,Weck, Stefanie C.,Ducho, Christian

, p. 16875 - 16887 (2020/11/30)

To overcome bacterial resistances, the need for novel antimicrobial agents is urgent. The class of so-called nucleoside antibiotics furnishes promising candidates for the development of new antibiotics, as these compounds block a clinically unexploited bacterial target: the integral membrane protein MraY, a key enzyme in cell wall (peptidoglycan) biosynthesis. Nucleoside antibiotics exhibit remarkable structural diversity besides their uridine-derived core motifs. Some sub-classes also show specific selectivities towards different Gram-positive and Gram-negative bacteria, which are poorly understood so far. Herein, the synthesis of a novel hybrid structure is reported, derived from the 5′-defunctionalized uridine core moiety of muraymycins and the peptide chain of sansanmycin B, as a new scaffold for the development of antimicrobial agents. The reported muraymycin–sansanmycin hybrid scaffold showed nanomolar activity against the bacterial target enzyme MraY, but displayed no significant antibacterial activity against S. aureus, E. coli, and P. aeruginosa.

Preparation and application of guaifenazulene aldole dicondensate (by machine translation)

-

Paragraph 0021; 0022, (2019/08/02)

The invention belongs to the field, and particularly relates to chemical preparation and application. When the problem group is subjected to chemical synthesis research on the skeleton by guaiguazulene and piperidine acid as raw materials, the derivative trans - 1, 2 - (1, 4 - diazulyl) ethene ene derivative of guaiabazulene is found. H1N1 Influenza virus testing, indicating that the compound is level, 25 mm in vitro antiviral activity superior to that of positive drug ribavirin. In vivo activity tests prove, the compound not only can inhibit the pneumonia symptoms, but also can reduce the titer, and the survival rate. , The survival rate, 5 mg/kg/day the lung virus titer . of virus-infected mice can be remarkably improved when stomach tube-like dosages are used for gastric lavage. In general, the activity of the compound is comparable, and the activity of the compound is comparable to that of oseltamivir. The utility model can be used for preparing antiviral drugs. The invention opens up a new way for deep research and development of new antiviral drugs, which is a new approach. (by machine translation)

KOtBu as a single electron donor? Revisiting the halogenation of alkanes with CBr4 and CCl4

Emery, Katie J.,Young, Allan,Arokianathar, J. Norman,Tuttle, Tell,Murphy, John A.

supporting information, (2018/05/22)

The search for reactions where KOtBu and other tert-alkoxides might behave as single electron donors led us to explore their reactions with tetrahalomethanes, CX4, in the presence of adamantane. We recently reported the halogenation of adamantane under these conditions. These reactions appeared to mirror the analogous known reaction of NaOH with CBr4 under phase-transfer conditions, where initiation features single electron transfer from a hydroxide ion to CBr4. We now report evidence from experimental and computational studies that KOtBu and other alkoxide reagents do not go through an analogous electron transfer. Rather, the alkoxides form hypohalites upon reacting with CBr4 or CCl4, and homolytic decomposition of appropriate hypohalites initiates the halogenation of adamantane.

SULFONAMIDE ANALOGUES OF GALIELLALACTONE

-

Page/Page column 43, (2018/06/30)

Disclosed are sulfonamide analogues of galiellactone of formula (I) as STAT3-inhibitors for use in the treatment of a STAT3 signaling related disorder, e.g. solid cancers, hematological cancers, benign tumors, hyperproliferative diseases, inflammations, autoimmune diseases, graft or transplant rejections, delayed physiological function of grafts or transplants, neurodegenerative diseases and viral infections. The sulfonamide comprises a cyclic substituent.

A head cefoxitin acid synthesis method

-

Paragraph 0026-0028, (2017/07/06)

The invention discloses a synthetic method of cefoxitin acid. Cephalotin acid used as a raw material reacts with prepared tert-butyl hypochlorite in the presence of sodium methylate to obtain a methoxy substance; the methoxy substance is subjected to a hydrolysis reaction and salt formation is carried out in the presence of benzathine to obtain methoxy cefalotin benzathine; methoxy cefalotin benzathine reacts with CSI, and hydrolysis is carried out to obtain a cefoxitin acid crude product; and the cefoxitin acid crude product undergoes the step of recrystallization to finally prepare cefoxitin acid. The synthetic method is simple to operate and is low-cost. By the synthetic method, quality and total yield reach 95.8%. The produced cefoxitin acid is a white solid powder, and purity of the product reaches more than 99.0%. The product has good quality and is suitable for industrial production.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 507-40-4